Status:
RECRUITING
Ketogenic Diet for Psychotic Disorders
Lead Sponsor:
Kuopio University Hospital
Collaborating Sponsors:
Deakin University
Conditions:
Psychosis; Acute
Psychosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Disturbances in glucose metabolism and glutamate neurotransmission feature in the pathophysiology of psychotic disorders. Ketogenic diet (KD) is a high-fat, low-carbohydrate diet that restricts glucos...
Detailed Description
Disturbances in glucose metabolism and glutamate neurotransmission feature in the pathophysiology of psychotic disorders. Ketogenic diet (KD) is a high-fat, low-carbohydrate diet that restricts glucos...
Eligibility Criteria
Inclusion
- ≥ 18 years old patient with psychotic symptoms / diagnosed psychotic disorder (ICD-10 diagnoses F20-F29)
Exclusion
- BMI \<18.5
- Diabetes mellitus (with or without insulin treatment)
- Inability to provide informed consent or to participate due to acute medical conditions, such as severe and acute psychotic symptoms or acute suicidality
- Impairments in vision, audition or immobility
- Pregnancy
- Diagnosed current eating disorder
- Diagnosed Inflammatory Bowel Disease (IBD)
- Severe alcohol or substance abuse
- Decompensated cardial insufficiency
- Infrequent/rare metabolic disorders, such as porphyria, disturbances in fatty acid oxidation or deficiency of CTT1, CPTII, carnitine or pyruvate carboxylase
- changes have occurred in psychotropic medications during the last 4 weeks
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03873922
Start Date
March 15 2021
End Date
December 31 2025
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kuopio University Hospital, Department of Psychiatry
Kuopio, Finland